IGF2BP3 and esophageal cancer: According to established clinical criteria (AUC > 0.7: moderate diagnostic value; AUC>0.9: high diagnostic utility), IGF2BP3 demonstrated high diagnostic capacity for esophageal cancer, suggesting strong diagnostic value for its detection.